{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:07:47Z","timestamp":1791925667567,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.taap.2024.117042","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T10:10:52Z","timestamp":1721988652000},"page":"117042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Liquidambaric acid inhibits the proliferation of hepatocellular carcinoma cells by targeting PPAR\u03b1-RXR\u03b1 to down-regulate fatty acid metabolism"],"prefix":"10.1016","volume":"490","author":[{"given":"Xinyun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jili","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.taap.2024.117042_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084517","article-title":"Synthesis, pharmacokinetic profile, anticancer activity and toxicity of the new amides of Betulonic acid-in silico and in vitro study[J]","volume":"25","author":"Bebenek","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.taap.2024.117042_bb0010","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer[J]","volume":"218","author":"Bian","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2024.117042_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111806","article-title":"Synthesis and biological evaluation of triterpenoid thiazoles derived from betulonic acid, dihydrobetulonic acid, and ursonic acid[J]","volume":"185","author":"Borkova","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"10064","key":"10.1016\/j.taap.2024.117042_bb0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial[J]","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.taap.2024.117042_bb0025","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1002\/jcp.30157","article-title":"Co-option of PPARalpha in the regulation of lipogenesis and fatty acid oxidation in CLA-induced hepatic steatosis[J]","volume":"236","author":"Cai","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.taap.2024.117042_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-020-0226-z","article-title":"ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK\/FBW7\/c-Myc axis[J]","volume":"9","author":"Chen","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.taap.2024.117042_bb0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2020.12.019","article-title":"ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc\/SREBP1 pathway[J]","volume":"502","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.taap.2024.117042_bb0040","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/molecules27031025","article-title":"Betulonic acid, as one of the active components of the Celastrus orbiculatus extract, inhibits the invasion and metastasis of gastric Cancer cells by mediating cytoskeleton rearrangement in vitro[J]","volume":"27","author":"Chu","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.taap.2024.117042_bb0045","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1158\/0008-5472.CAN-14-1192","article-title":"Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9\u2013mediated RXRA signaling pathway[J]","volume":"75","author":"Cui","year":"2015","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.taap.2024.117042_bb0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer[J]","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.taap.2024.117042_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/1735-5362.278714","article-title":"Evaluation of long-chain acyl-coenzyme a synthetase 4 (ACSL4) expression in human breast cancer[J]","volume":"15","author":"Dinarvand","year":"2020","journal-title":"Res Pharm Sci"},{"issue":"1","key":"10.1016\/j.taap.2024.117042_bb0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41401-020-0439-x","article-title":"ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma[J]","volume":"42","author":"Feng","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.taap.2024.117042_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","article-title":"Hepatocellular carcinoma: new developments[J]","volume":"27","author":"Ganesan","year":"2023","journal-title":"Clin. Liver Dis."},{"issue":"7","key":"10.1016\/j.taap.2024.117042_bb0070","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/apt.15464","article-title":"Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study[J]","volume":"50","author":"Gawrieh","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.taap.2024.117042_bb0075","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.clnu.2018.09.023","article-title":"Liver lipid metabolism disruption in cancer cachexia is aggravated by cla supplementation -induced inflammation[J]","volume":"38","author":"Goncalves","year":"2019","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.taap.2024.117042_bb0080","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/JHC.S251729","article-title":"Regorafenib combined with other systemic therapies: exploring promising therapeutic combinations in HCC[J]","volume":"8","author":"Granito","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.taap.2024.117042_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-nutr-071813-105541","article-title":"Acyl-CoA metabolism and partitioning[J]","volume":"34","author":"Grevengoed","year":"2014","journal-title":"Annu. Rev. Nutr."},{"issue":"8","key":"10.1016\/j.taap.2024.117042_bb0090","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41419-022-05137-5","article-title":"ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression[J]","volume":"13","author":"Grube","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2024.117042_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jnutbio.2016.09.015","article-title":"PPARalpha protects against trans-fatty-acid-containing diet-induced steatohepatitis[J]","volume":"39","author":"Hu","year":"2017","journal-title":"J. Nutr. Biochem."},{"issue":"4","key":"10.1016\/j.taap.2024.117042_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention[J]","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.taap.2024.117042_bb0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bbalip.2015.01.008","article-title":"PPARdelta activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro[J]","volume":"1851","author":"Kan","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.taap.2024.117042_bb0110","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular Cancer in patients with non-alcoholic fatty liver disease[J]","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.taap.2024.117042_bb0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer[J]","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.taap.2024.117042_bb0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbalip.2013.10.018","article-title":"Differentially localized acyl-CoA synthetase 4 isoenzymes mediate the metabolic channeling of fatty acids towards phosphatidylinositol[J]","volume":"1841","author":"Kuch","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"21","key":"10.1016\/j.taap.2024.117042_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105126","article-title":"CRISPR\/Cas9 screens reveal that hexokinase 2 enhances Cancer Stemness and Tumorigenicity by activating the ACSL4-fatty Acid\u03b2 -oxidation pathway[J]","volume":"9","author":"Li","year":"2022","journal-title":"Advanced Science"},{"issue":"4","key":"10.1016\/j.taap.2024.117042_bb0130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma[J]","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.taap.2024.117042_bb0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma[J]","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"10.1016\/j.taap.2024.117042_bb0140","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.3390\/ijms22073676","article-title":"Anticancer potential of Betulonic acid derivatives[J]","volume":"22","author":"Lombrea","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2024.117042_bb0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","article-title":"Fatty acid oxidation: an emerging facet of metabolic transformation in cancer[J]","volume":"435","author":"Ma","year":"2018","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.taap.2024.117042_bb0150","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41388-021-01667-y","article-title":"Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation[J]","volume":"40","author":"Ma","year":"2021","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.taap.2024.117042_bb0155","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/cas.13339","article-title":"ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells[J]","volume":"108","author":"Migita","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.taap.2024.117042_bb0160","doi-asserted-by":"crossref","first-page":"18669","DOI":"10.1038\/srep18669","article-title":"Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers[J]","volume":"6","author":"Nath","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.taap.2024.117042_bb0165","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200219","article-title":"Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases[J]","volume":"40","author":"Ndiaye","year":"2020","journal-title":"Biosci. Rep."},{"issue":"7","key":"10.1016\/j.taap.2024.117042_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040794","article-title":"The functional interaction between acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target[J]","volume":"7","author":"Orlando","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.taap.2024.117042_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001657","article-title":"Regorafenib enhances antitumor immunity via inhibition of p38 kinase\/Creb1\/Klf4 axis in tumor-associated macrophages[J]","volume":"9","author":"Ou","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.taap.2024.117042_bb0180","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.semcdb.2012.01.003","article-title":"PPARs: fatty acid sensors controlling metabolism[J]","volume":"23","author":"Poulsen","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.taap.2024.117042_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174397","article-title":"ACSL family: the regulatory mechanisms and therapeutic implications in cancer[J]","volume":"909","author":"Quan","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.taap.2024.117042_bb0190","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer[J]","volume":"16","author":"Rohrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.taap.2024.117042_bb0195","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/ijc.34404","article-title":"Chronic acidosis rewires cancer cell metabolism through PPARalpha signaling[J]","volume":"152","author":"Rolver","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.taap.2024.117042_bb0200","doi-asserted-by":"crossref","first-page":"11143","DOI":"10.1038\/s41598-017-11612-3","article-title":"Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cells[J]","volume":"7","author":"Sanchez-Martinez","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.taap.2024.117042_bb0205","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/ijc.32946","article-title":"ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5[J]","volume":"146","author":"Seo","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.taap.2024.117042_bb0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12885-023-10816-3","article-title":"SLC27A2 mediates FAO in colorectal cancer through nongenic crosstalk regulation of the PPARs pathway[J]","volume":"23","author":"Shang","year":"2023","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.taap.2024.117042_bb0215","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1071\/RD21380","article-title":"Betulonic acid regulates oviduct epithelial cell inflammation through the TLR4, MAPK, and JAK\/STAT signalling pathways[J]","volume":"35","author":"Shao","year":"2023","journal-title":"Reprod. Fertil. Dev."},{"issue":"3","key":"10.1016\/j.taap.2024.117042_bb0220","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101507RR","article-title":"A genome-wide CRISPR activation screen reveals hexokinase 1 as a critical factor in promoting resistance to multi-kinase inhibitors in hepatocellular carcinoma cells[J]","volume":"36","author":"Sofer","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2024.117042_bb0225","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jprot.2018.04.008","article-title":"Myristic acid induces proteomic and secretomic changes associated with steatosis, cytoskeleton remodeling, endoplasmic reticulum stress, protein turnover and exosome release in HepG2 cells[J]","volume":"181","author":"Speziali","year":"2018","journal-title":"J. Proteome"},{"issue":"9","key":"10.1016\/j.taap.2024.117042_bb0230","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1021\/acs.jmedchem.0c02124","article-title":"Betulonic acid derivatives interfering with human coronavirus 229E replication via the nsp15 endoribonuclease[J]","volume":"64","author":"Stevaert","year":"2021","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.taap.2024.117042_bb0235","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.taap.2024.117042_bb0240","first-page":"1390","article-title":"Fatty acid activation in carcinogenesis and cancer development: essential roles of long-chain acyl-CoA synthetases[J]","volume":"16","author":"Tang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"10360","key":"10.1016\/j.taap.2024.117042_bb0245","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma[J]","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2024.117042_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114232","article-title":"Paclitaxel and betulonic acid synergistically enhance antitumor efficacy by forming co-assembled nanoparticles[J]","volume":"182","author":"Wang","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.taap.2024.117042_bb0255","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41418-022-00974-5","article-title":"Activation of Drp1 promotes fatty acids-induced metabolic reprograming to potentiate Wnt signaling in colon cancer[J]","volume":"29","author":"Xiong","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.taap.2024.117042_bb0260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2022.04.132","article-title":"PPARalpha agonist WY-14,643 induces the PLA2\/COX-2\/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice[J]","volume":"613","author":"Xu","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.taap.2024.117042_bb0265","article-title":"PPARA\/RXRA signalling regulates the fate of hepatic non-esterified fatty acids in a sheep model of maternal undernutrition[J]","volume":"1865","author":"Xue","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"5","key":"10.1016\/j.taap.2024.117042_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110319","article-title":"Liquidambaric acid inhibits Wnt\/\u03b2-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2[J]","volume":"38","author":"Yan","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.taap.2024.117042_bb0275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.32538","article-title":"Intestinal peroxisome proliferator-activated receptor alpha-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis[J]","volume":"77","author":"Yan","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2024.117042_bb0280","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejmech.2015.04.006","article-title":"Synthesis and biological evaluation of betulonic acid derivatives as antitumor agents[J]","volume":"96","author":"Yang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.taap.2024.117042_bb0285","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management[J]","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.taap.2024.117042_bb0290","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.3390\/molecules25102454","article-title":"The synergistic anti-Cancer effects of NVP-BEZ235 and Regorafenib in hepatocellular carcinoma[J]","volume":"25","author":"Yu","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.taap.2024.117042_bb0295","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","article-title":"Identification of ACSL4 as a biomarker and contributor of ferroptosis[J]","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24002400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24002400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T23:25:59Z","timestamp":1723332359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24002400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":59,"alternative-id":["S0041008X24002400"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.117042","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquidambaric acid inhibits the proliferation of hepatocellular carcinoma cells by targeting PPAR\u03b1-RXR\u03b1 to down-regulate fatty acid metabolism","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.117042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117042"}}